亚太处方数字治疗 (PDTx) 市场 – 行业趋势和 2029 年预测

Customize Your Report Customize Your Report 立即购买 立即购买 免费样本报告 免费样本报告
Home Pharmaceutical Asia Pacific Prescription Digital Therapeutics Dtx Market
请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

亚太处方数字治疗 (PDTx) 市场 – 行业趋势和 2029 年预测

  • Pharmaceutical
  • Upcoming Report
  • May 2022
  • Asia-Pacific
  • 350 页面
  • 桌子數： 220
  • 图号： 60
立即购买 立即购买

Asia Pacific Prescription Digital Therapeutics Dtx Market

市场规模（十亿美元）

CAGR :  % Diagram

Chart Image USD 96.38 Billion USD 545.70 Billion 2021 2029
Diagram Forecast Period
 2022 –2029
Diagram Market Size (Base Year)
 USD 96.38 Billion
Diagram Market Size (Forecast Year)
 USD 545.70 Billion
Diagram CAGR
 %
Diagram Major Markets Players
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5
Request For Unlock

>亚太处方数字治疗 (PDTx) 市场，按机制（输入机制、输出机制）、类别（药物增强、药物替代）、治疗（门诊治疗、单一疗法）、软件（呼吸系统疾病软件、精神健康软件、阿片类药物使用障碍软件、糖尿病软件等）、服务（行为微服务、医疗微服务）、应用程序可访问性（Android、iOS、Windows）、应用程序类型（本机应用程序、Web 应用程序）、应用程序（物质使用障碍 (SUD)、阿片类药物使用障碍 (OUD)、注意力缺陷多动障碍 (ADHD)、阿尔茨海默病、重度抑郁症 (MDD)、失眠、癫痫、运动障碍、多发性硬化症、偏头痛、自闭症谱系障碍、肿瘤学、炎症、呼吸、心血管、疼痛管理、代谢状况、其他）、患者（儿童、成人）—— 2029 年行业趋势及预测

亚太处方数字治疗 (PDTx) 市场

Download PDF Get Exclusive Sample PDF of this Report Here

市场分析和规模                              

处方数字疗法是一种独特的策略，允许软件实施快速治疗主要疾病。它旨在随时随地提供循证治疗，并为医生提供有关患者进展的实时数据。处方数字疗法已经开发并处于多种疾病的开发阶段，包括物质使用障碍 (SUD)、阿片类药物使用障碍 (OUD)、注意力缺陷多动障碍 (ADHD)、重度抑郁症 (MDD)、失眠症、多发性硬化症、肿瘤学、偏头痛、癫痫、自闭症谱系障碍和心血管疾病。有各种未满足需求的患者可能会发现处方数字疗法是他们生活中最重要的方面。

Data Bridge Market Research 分析称，2021 年亚太处方数字疗法 (PDTx) 市场价值为 9638 万美元，预计到 2029 年将达到 5.457 亿美元，在 2022 年至 2029 年的预测期内复合年增长率为 24.2%。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外，Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、管道分析、定价分析和监管框架。

报告范围和市场细分

报告指标

细节

预测期

2022 至 2029 年

基准年

2021

历史岁月

2020（可定制为 2014 - 2019）

定量单位

收入（百万美元）、销量（单位）、定价（美元）

涵盖的领域

机制（输入机制、输出机制）、类别（药物增强、药物替代）、治疗（门诊治疗、单一疗法）、软件（呼吸系统疾病软件、精神健康软件、阿片类药物使用障碍软件、糖尿病软件等）、服务（行为微服务、医疗微服务）、应用可访问性（Android、iOS、Windows）、应用类型（原生应用、Web 应用）、应用程序（物质使用障碍 (SUD)、阿片类药物使用障碍 (OUD)、注意力缺陷多动障碍 (ADHD)、阿尔茨海默病、重度抑郁障碍 (MDD)、失眠、癫痫、运动障碍、多发性硬化症、偏头痛、自闭症谱系障碍、肿瘤学、炎症、呼吸系统、心血管、疼痛管理、代谢疾病等）、患者（儿童、成人）、

覆盖国家

亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 其他地区

涵盖的市场参与者

ResMed（美国）、SAMSUNGHEALTHCARE（韩国）、Biofourmis（美国）、Novartis AG（瑞士）、Medtronic（爱尔兰）、Pear Therapeutics, Inc.（美国）、Voluntis（法国）

市场机会
  • 增加研发活动数量
  • 强大的潜在产品线
Download PDF Get Exclusive Sample PDF of this Report Here

市场定义

处方数字疗法是一种用于治疗各种疾病的软件。处方数字药物是生物学和技术相结合而产生的。人工智能、各种算法和虚拟现实被用于创造这些治疗工具。患者可以使用处方数字治疗软件和服务随时随地获得任何形式的治疗。处方数字治疗已经获得了很大的普及，因为它们受到 FDA 和其他监管机构的严格监管，并且只能在医生的正确处方下使用。

亚太 处方数字化治疗 (PDTx) 市场动态

驱动程序

  • 慢性病患病率上升

慢性病患病率的激增 是推动处方数字疗法 (PDTx) 市场在 2022-2029 年预测期内增长率的主要因素。根据世界卫生组织 (WHO) 的数据，2020 年将有 4.63 亿成年人患有糖尿病。根据预测，到 2045 年，全球将有大约 6.29 亿糖尿病患者。

  • 增加医疗基础设施投资

影响处方数字治疗 (PDTx) 市场增长率的另一个重要因素是医疗支出的增加，这有助于改善其基础设施。此外，各政府组织旨在通过增加资金来改善医疗保健基础设施，这将进一步影响市场动态。

此外，智能手机和平板电脑的普及率不断提高将扩大处方数字治疗 (PDTx) 市场。此外，政府为改善医疗服务而采取的举措不断增多，老年人口不断增加，也将扩大处方数字治疗 (PDTx) 市场。除此之外，便捷的可及性、患者舒适度以及影响行为变化的潜力将提高市场的增长率。

机会

  • 强大的潜在产品线

预计在预测期内将发布的大量潜在产品将为处方数字疗法 (PDTx) 市场增长提供有利机会。Pear-011（焦虑症 GAD）、Pear-015（抑郁症 MDD）用于治疗患有慢性失眠和抑郁症的成年人，CT-152（重度抑郁症）、CT-155（精神分裂症）用于治疗患有精神分裂症和抑郁症的成年人，是处于 III 期的潜在 Pear 疗法临床治疗产品的代表。因此，预计各种处于研发阶段的后期药物将为数字疗法市场的繁荣提供诱人的前景。

市场的增长得益于研发活动的增加。这将为生物制剂市场的增长提供有利的机会。此外，在预测期内，对先进技术开发的投资增加和新兴市场数量的增加将进一步为处方数字疗法 (PDTx) 的增长提供有利的机会。

限制/挑战

另一方面，患者数据隐私问题将阻碍市场的增长速度。发展中经济体缺乏医疗基础设施和缺乏熟练的专业人员将对处方数字疗法 (PDTx) 市场构成挑战。此外，严格的政府法规和发展中国家对数字疗法缺乏认识将限制并进一步阻碍 2022-2029 年预测期内市场的增长率。

这份亚太处方数字疗法 (PDTx) 市场报告详细介绍了最新发展、贸易法规、进出口分析、生产分析、价值链优化、市场份额、国内和本地市场参与者的影响，分析了新兴收入来源、市场法规变化、战略市场增长分析、市场规模、类别市场增长、应用领域和主导地位、产品批准、产品发布、地域扩展、市场技术创新等方面的机会。如需了解有关亚太处方数字疗法 (PDTx) 市场的更多信息，请联系 Data Bridge Market Research 获取分析师简报，我们的团队将帮助您做出明智的市场决策，实现市场增长。

患者流行病学分析

处方数字疗法 (PDTx) 市场还为您提供详细的市场分析，包括患者分析、预后和治疗。患病率、发病率、死亡率、依从率是报告中提供的一些数据变量。分析流行病学对市场增长的直接或间接影响，以创建更稳健、更全面的队列多元统计模型，用于预测增长期的市场。

COVID-19 对亚太 处方数字治疗 (PDTx) 市场的影响

COVID-19对处方数字疗法 (PDTx) 行业产生了总体积极影响。这是由于全球对数字健康相关性、精神疾病的流行和药物使用率的认识不断提高。此外，由于人们在疫情期间被迫待在家里，体育锻炼减少、不健康的生活方式和精神压力增加了慢性病的患病率。因此，全球对处方数字疗法 (PDTx) 设备和软件的需求正在增加。由于最近放松了对处方数字疗法 (PDTx) 治疗的监管许可，预计该行业将进一步增长。

在新冠疫情期间，美国FDA对Pear Therapeutics的精神健康药物发出了临时建议，这也意味着监管机构认识到数字治疗产品的重要性。此外，美国数字健康企业在2020年上半年筹集了54亿美元的风险投资，创下了数字健康融资历史上的最高纪录，表明投资者认为这些解决方案是必要的。因此，新冠疫情预计将推动处方数字治疗（PDTx）市场的发展。

亚太处方数字化治疗 (PDTx) 市场范围

亚太处方数字治疗 (PDTx) 市场根据机制、类别、治疗、软件、服务、应用可访问性、应用类型、应用和患者进行细分。这些细分市场之间的增长将帮助您分析行业中增长微弱的细分市场，并为用户提供有价值的市场概览和市场洞察，帮助他们做出战略决策，确定核心市场应用。

机制

  • 输入机制
  • 输出机制

类别

  • 药物增强
  • 药物替代

治疗

  • 门诊治疗
  • 单药治疗

软件

  • 呼吸系统疾病软件
  • 心理健康软件
  • 阿片类药物使用障碍软件
  • 糖尿病软件
  • 其他的

服务

  • 行为微服务
  • 医疗微服务

应用程序辅助功能

  • 安卓
  • iOS
  • 视窗

应用类型

  • 原生应用
  • Web 应用

应用

  • 物质使用障碍 (SUD)
  • 阿片类药物使用障碍 (OUD)
  • 注意力缺陷多动障碍 (ADHD)
  • 阿尔茨海默病
  • 重度抑郁症（MDD）
  • 失眠
  • 癫痫
  • 运动障碍
  • 多发性硬化症
  • 偏头痛
  • 自闭症谱系障碍
  • 肿瘤学
  • 炎
  • 呼吸系统
  • 心血管
  • 疼痛管理
  • 代谢状况
  • 其他的

患者

  • 孩子们
  • 成年人

亚太 处方数字治疗 (PDTx) 市场区域分析/见解

对亚太处方数字治疗 (PDTx) 市场进行分析，并按国家、机制、类别、治疗、软件、服务、应用程序可访问性、应用程序类型、应用程序和患者提供市场规模洞察和趋势。

亚太处方数字治疗（PDTx）市场报告涵盖的国家包括亚太地区（APAC）的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾和亚太地区（APAC）其他地区。

日本在市场份额和市场收入方面占据亚太处方数字治疗 (PDTx) 市场的主导地位，并将在预测期内继续保持主导地位。这是因为医疗支出的增加和慢性病患病率的上升将进一步推动该地区市场的增长率。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化影响了市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了亚太品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。   

竞争格局和亚太 处方数字治疗 (PDTx) 市场份额分析

亚太处方数字疗法 (PDTx) 市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、亚太业务、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对亚太处方数字疗法 (PDTx) 市场的关注有关。

亚太处方数字治疗 (PDTx) 市场的一些主要参与者包括：

  • ResMed（美国）
  • 三星医疗保健（韩国）
  • Biofourmis（美国）
  • 诺华公司（瑞士）
  • 美敦力（爱尔兰）
  • Pear Therapeutics, Inc.（美国）
  • Voluntis（法国）

SKU-

Get online access to the report on the World's First Market Intelligence Cloud

Sample Image Click on image to enlarge
  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

目录

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 MECHANISM OF PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 MARKET APPLICATION COVERAGE GRID

2.11 VENDOR SHARE ANALYSIS

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INESIGHT

4.1 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: LAWS AND REGULATIONS

4.2 PRINCIPLES FOR THE DEVELOPMENT OF PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) GUIDELINES

4.3 HIPAA COMPLIANCE FOR PRESCRIPTION DIGITAL THERAPEUTICS (PDTX)

5 EPIDERMOLOGY

6 PIPELINE ANALYSIS

6.1 LIST OF PIPELINE PRODUCTS

7 MARKET OVERVIEW

7.1 DRIVERS

7.1.1 PRESENCE OF PRODUCT PIPELINE

7.1.2 INCREASING PREVALANCE OF DISEASES

7.1.3 HIGH DEMAND OF PDTX DUE TO THEIR HIGH COST EFFECTIVENESS

7.1.4 INCREASINGLY DOMINANT ROLE OF MOBILE TECHNOLOGY AND ARTIFICIAL INTELLIGENCE (AI) IN OUR EVERYDAY LIVES

7.1.5 PRESENCE OF REIMBURSEMENT

7.2 RESTRAINTS

7.2.1 UNAFFORDABILITY OF DIGITAL THERAPEUTICS

7.2.2 PRIVACY ISSUES IN PRESCRIPTION DIGITAL HEALTHCARE

7.2.3 RESISTANCE FROM TRADITIONAL HEALTHCARE PROVIDERS

7.3 OPPORTUNITIES

7.3.1 INCREASING FUNDING ACTIVITIES

7.3.2 STRATEGIC INITIATIVES BY MARKET PLAYERS

7.3.3 EXPLORATION OF EMERGING MARKET

7.3.4 INCREASING HEALTHCARE EXPENDITURE

7.4 CHALLENGES

7.4.1 LACK OF SKILLED RESOURCES

7.4.2 EXISTENCE OF TRADITIONAL MEDICATIONS

7.4.3 LONG APPROVAL PROCEDURE

8 IMPACT OF COVID-19 PANDEMIC ON THE ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET

8.1 PRICE IMPACT

8.2 IMPACT ON DEMAND

8.3 IMPACT ON SUPPLY CHAIN

8.4 STRATEGIC DECISIONS FOR MANUFACTURERS

8.5 CONCLUSION

9 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM

9.1 OVERVIEW

9.2 INPUT MECHANISMS

9.2.1 PATIENT DATA COLLECTION

9.2.1.1 Cognition

9.2.1.2 Mood

9.2.1.3 Memory

9.2.1.4 Concentration

9.2.1.5 Familial Recognition

9.2.1.6 Others

9.2.2 DEXTERITY OR STEADINESS MEASUREMENT

9.2.2.1 Range of Motion Tests

9.2.2.2 Stretching

9.2.2.3 Others

9.2.3 AUDIO ANALYSIS

9.2.3.1 Shakiness

9.2.3.2 Voice Quality

9.2.3.3 Others

9.2.3.4 Screen

9.2.3.5 Accelerometer

9.2.3.6 Microphone

9.3 OUTPUT MECHANISMS

9.3.1 PATIENT COMMUNICATION

9.3.1.1 Professional Coaching

9.3.1.2 Peer-to-Peer Support

9.3.1.3 Others

9.3.2 ADHERENCE PROMPTS

9.3.2.1 Sleep

9.3.2.2 Diet

9.3.2.3 Inactivity

9.3.2.4 Others

9.3.3 CONTENT DELIVERY

9.3.3.1 Blogs

9.3.3.2 Tips

9.3.3.3 Videos

9.3.3.4 FAQs

9.3.3.5 Others

9.3.3.6 Chat

9.3.3.7 Notification

10 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY

10.1 OVERVIEW

10.2 MEDICATION AUGMENTATION

10.3 MEDICATION REPLACEMENT

11 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT

11.1 OVERVIEW

11.2 OUTPATIENT TREATMENT

11.2.1 COGNITIVE BEHAVIOR THERAPY (CBT)

11.2.2 CONTINGENCY MANAGEMENT

11.2.3 CRAVING OR TRIGGER ASSESSMENT

11.2.4 FLUENCY TRAINING

11.2.5 TRANSMUCOSAL BUPRENORPHINE

11.2.6 OTHERS

11.3 MONOTHERAPY

11.3.1 COGNITIVE RESTRUCTURING

11.3.2 INSOMNIA-SPECIFIC COGNITIVE BEHAVIORAL THERAPY (CBT)

11.3.3 OTHERS

12 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE

12.1 OVERVIEW

12.2 4.2 SOFTWARE FOR DIABETES

12.3 SOFTWARE FOR MENTAL HEALTH

12.4 SOFTWARE FOR RESPIRATORY CONDITIONS

12.5 SOFTWARE FOR OPIOID USE DISORDER

12.6 OTHERS

13 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES

13.1 OVERVIEW

13.2 BEHAVIORAL MICROSERVICES

13.2.1 PHYSICAL ACTIVITY

13.2.2 TELEMEDICINE

13.2.3 CONTROLLED BREATHING

13.2.4 MINDFULNESS TRAINING

13.2.5 RELAXATION TECHNIQUE

13.2.6 DIET OPTIMIZATION

13.2.7 OTHERS

13.3 MEDICAL MICROSERVICES

13.3.1 MEDICATION MANAGEMENT SYSTEM

13.3.2 PATIENT HEALTH QUESTIONNAIRE

13.3.3 HEALTH RECOVERED ENGINE

13.3.4 FAGERSTRÖM TEST

13.3.5 MORISKY MEDICATION ADHERENCE SCALE

13.3.6 FINANCIAL SAVING ENGINE

13.3.7 OTHERS

14 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY

14.1 OVERVIEW

14.2 ANDROID

14.2.1 SMARTPHONE

14.2.2 TABLET

14.3 OS

14.3.1 SMARTPHONE

14.3.2 TABLET

14.4 WINDOWS

14.4.1 SMARTPHONE

14.4.2 TABLET

15 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE

15.1 OVERVIEW

15.2 NATIVE APPS

15.3 WEB APPS

16 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION

16.1 OVERVIEW

16.2 METABOLIC CONDITIONS

16.3 MAJOR DEPRESSIVE DIORDER (MDD)

16.4 RESPIRATORY

16.5 CARDIOVASCULAR

16.6 SUBSTANCE USE DISORDER (SUD)

16.7 OPIOID USE DISORDERS (OUD)

16.8 INSOMNIA

16.9 PAIN MANAGEMENT

16.1 ATTENTION DEFICIT/HYPERACTIVITY DISORDER (ADHD)

16.11 MOVEMENT DISORDER

16.12 INFLAMMATION

16.13 ONCOLOGY

16.14 MIGRAINE

16.15 ALZHEIMER’S DISEASE

16.16 EPILEPSY

16.17 MULTIPLE SCLEROSIS

16.18 AUSTISM SPECTRUM DISORDER

16.19 OTHERS

17 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY PATIENTS

17.1 OVERVIEW

17.2 ADULTS

17.3 CHILDREN

18 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY GEOGRAPHY

18.1 ASIA -PACIFIC

18.1.1 JAPAN

18.1.2 CHINA

18.1.3 AUSTRALIA

18.1.4 SOUTH KOREA

18.1.5 INDIA

18.1.6 SINGAPORE

18.1.7 THAILAND

18.1.8 MALAYSIA

18.1.9 INDONESIA

18.1.10 PHILIPPINES

18.1.11 VIETNAM

18.1.12 REST OF ASIA- PACIFIC

19 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: COMPANY LANDSCAPE

19.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

20 SWOT ANALYSIS

21 COMPANY PROFILE

21.1 OMADA HEALTH, INC.

21.1.1 COMPANY SNAPSHOT

21.1.2 PRODUCT PORTFOLIO

21.1.3 RECENT DEVELOPMENTS

21.2 RESMED

21.2.1 COMPANY SNAPSHOT

21.2.2 REVENUE ANALYSIS

21.2.3 COMPANY SHARE ANALYSIS

21.2.4 PRODUCT PORTFOLIO

21.2.5 RECENT DEVELOPMENTS

21.3 SAMSUNG

21.3.1 COMPANY SNAPSHOT

21.3.2 REVENUE ANALYSIS

21.3.3 COMPANY SHARE ANALYSIS

21.3.4 PRODUCT PORTFOLIO

21.3.5 RECENT DEVELOPMENT

21.4 GAIA AG

21.4.1 COMPANY SNAPSHOT

21.4.2 COMPANY SHARE ANALYSIS

21.4.3 PRODUCT PORTFOLIO

21.4.4 RECENT DEVELOPMENTS

21.5 PEAR THERAPEUTICS, INC.

21.5.1 COMPANY SNAPSHOT

21.5.2 COMPANY SHARE ANALYSIS

21.5.3 PRODUCT PORTFOLIO

21.5.4 RECENT DEVELOPMENTS

21.6 WELLDOC’S BLUESTAR

21.6.1 COMPANY SNAPSHOT

21.6.2 PRODUCT PORTFOLIO

21.6.3 RECENT DEVELOPMENTS

21.7 SOLERA NETWORK

21.7.1 COMPANY SNAPSHOT

21.7.2 PRODUCT PORTFOLIO

21.7.3 RECENT DEVELOPMENTS

21.8 AKILI INTERACTIVE LABS, INC.

21.8.1 COMPANY SNAPSHOT

21.8.2 PRODUCT PORTFOLIO

21.8.3 RECENT DEVELOPMENTS

21.9 BETTER THERAPEUTICS, LLC

21.9.1 COMPANY SNAPSHOT

21.9.2 PIPELINE PRODUCT PORTFOLIO

21.9.3 RECENT DEVELOPMENTS

21.1 BIGHEALTH

21.10.1 COMPANY SNAPSHOT

21.10.2 SOLUTION PORTFOLIO

21.10.3 RECENT DEVELOPMENT

21.11 BIOFOURMIS

21.11.1 COMPANY SNAPSHOT

21.11.2 PRODUCT PORTFOLIO

21.11.3 RECENT DEVELOPMENTS

21.12 CLICK THERAPEUTICS, INC.

21.12.1 COMPANY SNAPSHOT

21.12.2 PRODUCT PORTFOLIO

21.12.3 RECENT DEVELOPMENTS

21.13 HAPPIFY, INC.

21.13.1 COMPANY SNAPSHOT

21.13.2 PRODUCT PORTFOLIO

21.13.3 RECENT DEVELOPMENTS

21.14 LIMBIX HEALTH, INC.

21.14.1 COMPANY SNAPSHOT

21.14.2 PRODUCT PORTFOLIO

21.14.3 RECENT DEVELOPMENTS

21.15 NATURALCYCLES NORDIC AB

21.15.1 COMPANY SNAPSHOT

21.15.2 PRODUCT PORTFOLIO

21.15.3 RECENT DEVELOPMENTS

21.16 NUVOAIR AB

21.16.1 COMPANY SNAPSHOT

21.16.2 PRODUCT PORTFOLIO

21.16.3 RECENT DEVELOPMENTS

21.17 SENSYNE HEALTH PLC

21.17.1 COMPANY SNAPSHOT

21.17.2 REVENUE ANALYSIS

21.17.3 PRODUCT PORTFOLIO

21.17.4 RECENT DEVELOPMENTS

21.18 VOLUNTIS

21.18.1 COMPANY SNAPSHOT

21.18.2 REVENUE ANALYSIS

21.18.3 PRODUCT PORTFOLIO

21.18.4 RECENT DEVELOPMENTS

21.19 XEALTH

21.19.1 COMPANY SNAPSHOT

21.19.2 PRODUCT PORTFOLIO

21.19.3 RECENT DEVELOPMENTS

22 QUESTIONNAIRE

23 RELATED REPORTS

表格列表

LIST OF TABLES

TABLE 1 REGULATORY FRAMEWORK

TABLE 2 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, PIPELINE ANALYSIS

TABLE 3 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM 2019-2027 (USD MILLION)

TABLE 4 ASIA-PACIFIC INPUT MECHANISMS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 5 ASIA-PACIFIC INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 6 ASIA-PACIFIC PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 7 ASIA-PACIFIC DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 8 ASIA-PACIFIC AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 9 ASIA-PACIFICINPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 10 ASIA-PACIFIC OUTPUT MECHANISMS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 11 ASIA-PACIFIC OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 12 ASIA-PACIFIC PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 13 ASIA-PACIFIC ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 14 ASIA-PACIFIC CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 15 ASIA-PACIFIC OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 16 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY 2019-2027 (USD MILLION)

TABLE 17 ASIA-PACIFIC MEDICATION AUGMENTATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 18 ASIA-PACIFIC MEDICATION REPLACEMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 19 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT 2019-2027 (USD MILLION)

TABLE 20 ASIA-PACIFIC OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 21 ASIA-PACIFIC OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 22 ASIA-PACIFIC MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 23 ASIA-PACIFIC MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 24 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE 2019-2027 (USD MILLION)

TABLE 25 ASIA-PACIFIC SOFTWARE FOR DIABETES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 26 ASIA-PACIFIC SOFTWARE FOR MENTAL HEALTH IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 27 ASIA-PACIFIC SOFTWARE FOR RESPIRATORY CONDITIONS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 28 ASIA-PACIFIC SOFTWARE FOR OPIOID USE DIOSRDER IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 29 ASIA-PACIFIC OTHERS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 30 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES 2019-2027 (USD MILLION)

TABLE 31 ASIA-PACIFIC BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 32 ASIA-PACIFIC BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 33 ASIA-PACIFIC MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 34 ASIA-PACIFIC MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 35 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY 2019-2027 (USD MILLION)

TABLE 36 ASIA-PACIFIC ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 37 ASIA-PACIFIC ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2017-2027 (USD MILLION)

TABLE 38 ASIA-PACIFIC IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 39 ASIA-PACIFIC IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2017-2027 (USD MILLION)

TABLE 40 ASIA-PACIFIC WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 41 ASIA-PACIFIC WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2017-2027 (USD MILLION)

TABLE 42 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2019-2027 (USD MILLION)

TABLE 43 ASIA-PACIFIC NATIVE APPS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 44 ASIA-PACIFIC WEB APPS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 45 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2019-2027 (USD MILLION)

TABLE 46 ASIA-PACIFIC METABOLIC CONDITIONS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 47 ASIA-PACIFIC MAJOR DEPRESSIVE DISORDER IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 48 ASIA-PACIFIC RESPIRATORY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 49 ASIA-PACIFIC CARDIOVASCULAR IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 50 ASIA-PACIFIC SUBSTANCE USE DISORDERS (SUD) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 51 ASIA-PACIFIC OPIOID USE DISORDER IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 52 ASIA-PACIFIC INSOMNIA IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 53 ASIA-PACIFIC PAIN MANAGEMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 54 ASIA-PACIFIC ATTENTION DEFICIT/HYPERACTIVITY DISORDER (ADHD) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 55 ASIA-PACIFIC MOVEMENT DISORDER IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 56 ASIA-PACIFIC INFLAMMATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 57 ASIA-PACIFIC ONCOLOGY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 58 ASIA-PACIFIC MIGRAINE IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 59 ASIA-PACIFIC ALZHEIMER’S DISEASE IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 60 ASIA-PACIFIC EPILEPSY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 61 ASIA-PACIFIC MULTIPLE SCLEROSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 62 ASIA-PACIFIC AUTISM SPECTRUM DISORDERIN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 63 ASIA-PACIFIC OTHER IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 64 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY PATIENTS 2019-2027 (USD MILLION)

TABLE 65 ASIA-PACIFIC ADULTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 66 ASIA-PACIFIC CHILDREN IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 67 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY COUNTRY, 2018-2027 (USD MILLION)

TABLE 68 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 69 ASIA- PACIFIC INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 70 ASIA- PACIFIC PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 71 ASIA- PACIFIC DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 72 ASIA- PACIFIC AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 73 ASIA- PACIFIC INPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 74 ASIA- PACIFIC OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 75 ASIA- PACIFIC PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 76 ASIA- PACIFIC ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 77 ASIA- PACIFIC CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 78 ASIA- PACIFIC OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 79 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY, 2018-2027 (USD MILLION)

TABLE 80 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 81 ASIA- PACIFIC OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 82 ASIA- PACIFIC MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 83 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE, 2018-2027 (USD MILLION)

TABLE 84 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 85 ASIA- PACIFIC BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 86 ASIA- PACIFIC MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 87 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 88 ASIA- PACIFIC ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 89 ASIA- PACIFIC IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 90 ASIA- PACIFIC WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 91 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2018-2027 (USD MILLION)

TABLE 92 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2018-2027 (USD MILLION)

TABLE 93 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (DTX) MARKET, BY PATIENTS 2018-2027 (USD MILLION)

TABLE 94 JAPAN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 95 JAPAN INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 96 JAPAN PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 97 JAPAN DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 98 JAPAN AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 99 JAPAN INPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 100 JAPAN OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 101 JAPAN PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 102 JAPAN ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 103 JAPAN CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 104 JAPAN OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 105 JAPAN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY, 2018-2027 (USD MILLION)

TABLE 106 JAPAN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 107 JAPAN OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 108 JAPAN MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 109 JAPAN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE, 2018-2027 (USD MILLION)

TABLE 110 JAPAN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 111 JAPAN BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 112 JAPAN MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 113 JAPAN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 114 JAPAN ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 115 JAPAN IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 116 JAPAN WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 117 JAPAN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2018-2027 (USD MILLION)

TABLE 118 JAPAN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2018-2027 (USD MILLION)

TABLE 119 JAPAN PRESCRIPTION DIGITAL THERAPEUTICS (DTX) MARKET, BY PATIENTS 2018-2027 (USD MILLION)

TABLE 120 CHINA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 121 CHINA INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 122 CHINA PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 123 CHINA DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 124 CHINA AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 125 CHINA INPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 126 CHINA OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 127 CHINA PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 128 CHINA ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 129 CHINA CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 130 CHINA OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 131 CHINA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY, 2018-2027 (USD MILLION)

TABLE 132 CHINA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 133 CHINA OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 134 CHINA MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 135 CHINA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE, 2018-2027 (USD MILLION)

TABLE 136 CHINA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 137 CHINA BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 138 CHINA MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 139 CHINA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 140 CHINA ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 141 CHINA IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 142 CHINA WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 143 CHINA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2018-2027 (USD MILLION)

TABLE 144 CHINA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2018-2027 (USD MILLION)

TABLE 145 CHINA PRESCRIPTION DIGITAL THERAPEUTICS (DTX) MARKET, BY PATIENTS 2018-2027 (USD MILLION)

TABLE 146 AUSTRALIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 147 AUSTRALIA INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 148 AUSTRALIA PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 149 AUSTRALIA DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 150 AUSTRALIA AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 151 AUSTRALIA INPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 152 AUSTRALIA OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 153 AUSTRALIA PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 154 AUSTRALIA ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 155 USTRALIA CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 156 AUSTRALIA OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 157 AUSTRALIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY, 2018-2027 (USD MILLION)

TABLE 158 AUSTRALIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 159 AUSTRALIA OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 160 AUSTRALIA MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 161 AUSTRALIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE, 2018-2027 (USD MILLION)

TABLE 162 AUSTRALIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 163 AUSTRALIA BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 164 AUSTRALIA MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 165 AUSTRALIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 166 AUSTRALIA ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 167 AUSTRALIA IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 168 AUSTRALIA WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 169 AUSTRALIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2018-2027 (USD MILLION)

TABLE 170

TABLE 171 USTRALIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2018-2027 (USD MILLION)

TABLE 172 AUSTRALIA PRESCRIPTION DIGITAL THERAPEUTICS (DTX) MARKET, BY PATIENTS 2018-2027 (USD MILLION)

TABLE 173 SOUTH KOREA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 174 SOUTH KOREA INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 175 SOUTH KOREA PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 176 SOUTH KOREA DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 177 SOUTH KOREA AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 178 SOUTH KOREA INPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 179 SOUTH KOREA OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 180 SOUTH KOREA PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 181 SOUTH KOREA ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 182 SOUTH KOREA CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 183 SOUTH KOREA OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 184 SOUTH KOREA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY, 2018-2027 (USD MILLION)

TABLE 185 SOUTH KOREA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 186 SOUTH KOREA OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 187 SOUTH KOREA MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 188 SOUTH KOREA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE, 2018-2027 (USD MILLION)

TABLE 189 SOUTH KOREA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 190 SOUTH KOREA BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 191 SOUTH KOREA MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 192 SOUTH KOREA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 193 SOUTH KOREA ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 194 SOUTH KOREA IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 195 SOUTH KOREA WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 196 SOUTH KOREA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2018-2027 (USD MILLION)

TABLE 197 SOUTH KOREA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2018-2027 (USD MILLION)

TABLE 198 SOUTH KOREA PRESCRIPTION DIGITAL THERAPEUTICS (DTX) MARKET, BY PATIENTS 2018-2027 (USD MILLION)

TABLE 199 INDIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 200 INDIA INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 201 INDIA PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 202 INDIA DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 203 INDIA AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 204 INDIA INPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 205 INDIA OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 206 INDIA PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 207 INDIA ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 208 INDIA CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 209 INDIA OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 210 INDIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY, 2018-2027 (USD MILLION)

TABLE 211 INDIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 212 INDIA OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 213 INDIA MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 214 INDIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE, 2018-2027 (USD MILLION)

TABLE 215 INDIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 216 INDIA BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 217 INDIA MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 218 INDIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 219 INDIA ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 220 INDIA IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 221 INDIA WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 222 INDIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2018-2027 (USD MILLION)

TABLE 223 INDIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2018-2027 (USD MILLION)

TABLE 224 INDIA PRESCRIPTION DIGITAL THERAPEUTICS (DTX) MARKET, BY PATIENTS 2018-2027 (USD MILLION)

TABLE 225 SINGAPORE PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 226 SINGAPORE INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 227 SINGAPORE PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 228 SINGAPORE DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 229 SINGAPORE AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 230 SINGAPORE INPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 231 INGAPORE OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 232 SINGAPORE PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 233 SINGAPORE ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 234 SINGAPORE CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 235 SINGAPORE OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 236 SINGAPORE PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY, 2018-2027 (USD MILLION)

TABLE 237 SINGAPORE PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 238 SINGAPORE OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 239 SINGAPORE MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 240 SINGAPORE PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE, 2018-2027 (USD MILLION)

TABLE 241 SINGAPORE PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 242 SINGAPORE BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 243 SINGAPORE MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 244 SINGAPORE PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 245 SINGAPORE ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 246 SINGAPORE IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 247 SINGAPORE WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 248 SINGAPORE PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2018-2027 (USD MILLION)

TABLE 249 SINGAPORE PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2018-2027 (USD MILLION)

TABLE 250 SINGAPORE PRESCRIPTION DIGITAL THERAPEUTICS (DTX) MARKET, BY PATIENTS 2018-2027 (USD MILLION)

TABLE 251 THAILAND PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 252 THAILAND INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 253 THAILAND PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 254 THAILAND DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 255 THAILAND AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 256 THAILAND INPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 257 THAILAND OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 258 THAILAND PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 259 THAILAND ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 260 THAILAND CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 261 THAILAND OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 262 THAILAND PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY, 2018-2027 (USD MILLION)

TABLE 263 THAILAND PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 264 THAILAND OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 265 THAILAND MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 266 THAILAND PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE, 2018-2027 (USD MILLION)

TABLE 267 THAILAND PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 268 THAILAND BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 269 THAILAND MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 270 THAILAND PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 271 THAILAND ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 272 THAILAND IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 273 THAILAND WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 274 THAILAND PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2018-2027 (USD MILLION)

TABLE 275 THAILAND PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2018-2027 (USD MILLION)

TABLE 276 THAILAND PRESCRIPTION DIGITAL THERAPEUTICS (DTX) MARKET, BY PATIENTS 2018-2027 (USD MILLION)

TABLE 277 MALAYSIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 278 MALAYSIA INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 279 MALAYSIA PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 280 MALAYSIA DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 281 MALAYSIA AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 282 MALAYSIA INPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 283 MALAYSIA OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 284 MALAYSIA PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 285 MALAYSIA ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 286 MALAYSIA CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 287 MALAYSIA OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 288 MALAYSIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY, 2018-2027 (USD MILLION)

TABLE 289 MALAYSIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 290 MALAYSIA OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 291 MALAYSIA MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 292 MALAYSIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE, 2018-2027 (USD MILLION)

TABLE 293 MALAYSIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 294 MALAYSIA BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 295 MALAYSIA MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 296 MALAYSIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 297 MALAYSIA ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 298 MALAYSIA IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 299 MALAYSIA WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 300 MALAYSIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2018-2027 (USD MILLION)

TABLE 301 MALAYSIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2018-2027 (USD MILLION)

TABLE 302 MALAYSIA PRESCRIPTION DIGITAL THERAPEUTICS (DTX) MARKET, BY PATIENTS 2018-2027 (USD MILLION)

TABLE 303 INDONESIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 304 INDONESIA INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 305 INDONESIA PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 306 INDONESIA DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 307 INDONESIA AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 308 INDONESIA INPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 309 INDONESIA OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 310 INDONESIA PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 311 INDONESIA ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 312 INDONESIA CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 313 INDONESIA OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 314 INDONESIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY, 2018-2027 (USD MILLION)

TABLE 315 INDONESIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 316 INDONESIA OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 317 INDONESIA MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 318 INDONESIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE, 2018-2027 (USD MILLION)

TABLE 319 INDONESIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 320 INDONESIA BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 321 INDONESIA MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 322 INDONESIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 323 INDONESIA ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 324 INDONESIA IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 325 INDONESIA WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 326 INDONESIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2018-2027 (USD MILLION)

TABLE 327 INDONESIA PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2018-2027 (USD MILLION)

TABLE 328 INDONESIA PRESCRIPTION DIGITAL THERAPEUTICS (DTX) MARKET, BY PATIENTS 2018-2027 (USD MILLION)

TABLE 329 PHILIPPINES PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 330 PHILIPPINES INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 331 PHILIPPINES PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 332 PHILIPPINES DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 333 PHILIPPINES AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 334 PHILIPPINES INPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 335 HILIPPINES OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 336 PHILIPPINES PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 337 PHILIPPINES ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 338 PHILIPPINES CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 339 PHILIPPINES OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 340 PHILIPPINES PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY, 2018-2027 (USD MILLION)

TABLE 341 PHILIPPINES PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 342 PHILIPPINES OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 343 PHILIPPINES MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 344 PHILIPPINES PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE, 2018-2027 (USD MILLION)

TABLE 345 PHILIPPINES PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 346 PHILIPPINES BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 347 PHILIPPINES MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 348 PHILIPPINES PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 349 PHILIPPINES ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 350 PHILIPPINES IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 351 PHILIPPINES WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 352 PHILIPPINES PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2018-2027 (USD MILLION)

TABLE 353 PHILIPPINES PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2018-2027 (USD MILLION)

TABLE 354 PHILIPPINES PRESCRIPTION DIGITAL THERAPEUTICS (DTX) MARKET, BY PATIENTS 2018-2027 (USD MILLION)

TABLE 355 VIETNAM PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 356 VIETNAM INPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 357 VIETNAM PATIENT DATA COLLECTION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 358 VIETNAM DEXTERITY OR STEADINESS MEASUREMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 359 VIETNAM AUDIO ANALYSIS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 360 VIETNAM INPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 361 VIETNAM OUTPUT MECHANISM (BY APPLICATION) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 362 VIETNAM PATIENT COMMUNICATION IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 363 VIETNAM ADHERENCE PROMPTS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 364 VIETNAM CONTENT DELIVERY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 365 VIETNAM OUTPUT MECHANISM (BY TYPE) IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

TABLE 366 VIETNAM PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY CATEGORY, 2018-2027 (USD MILLION)

TABLE 367 VIETNAM PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 368 VIETNAM OUTPATIENT TREATMENT IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 369 VIETNAM MONOTHERAPY IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)

TABLE 370 VIETNAM PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SOFTWARE, 2018-2027 (USD MILLION)

TABLE 371 VIETNAM PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 372 VIETNAM BEHAVIORAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 373 VIETNAM MEDICAL MICROSERVICES IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY SERVICES, 2018-2027 (USD MILLION)

TABLE 374 VIETNAM PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 375 VIETNAM ANDROID IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 376 VIETNAM IOS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 377 VIETNAM WINDOWS IN PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP ACCESSIBILITY, 2018-2027 (USD MILLION)

TABLE 378 VIETNAM PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APP TYPE 2018-2027 (USD MILLION)

TABLE 379 VIETNAM PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY APPLICATION 2018-2027 (USD MILLION)

TABLE 380 VIETNAM PRESCRIPTION DIGITAL THERAPEUTICS (DTX) MARKET, BY PATIENTS 2018-2027 (USD MILLION)

TABLE 381 REST OF ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET, BY MECHANISM, 2018-2027 (USD MILLION)

图片列表

LIST OF FIGURES

FIGURE 1 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: SEGMENTATION

FIGURE 2 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: SEGMENTATION

FIGURE 3 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: DROC ANALYSIS

FIGURE 4 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: ASIA-PACIFIC VS REGIONAL MARKET ANALYSIS

FIGURE 5 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: MULTIVARIATE MODELLING

FIGURE 7 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: DBMR MARKET POSITION GRID

FIGURE 9 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 10 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: VENDOR SHARE ANALYSIS

FIGURE 11 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: SEGMENTATION

FIGURE 12 INCREASINGLY DOMINANT ROLE OF MOBILE TECHNOLOGY AND ARTIFICIAL INTELLIGENCE (AI) IN OUR EVERYDAY LIVES AND HIGH DEMAND OF PDTX DUE TO THEIR HIGH COST EFFECTIVENESS IS DRIVING THE ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET IN THE FORECAST PERIOD OF 2020 TO 2027

FIGURE 13 INPUT MECHANISMS IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET IN 2020 & 2027

FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET

FIGURE 15 DEATH CAUSE IN EUROPEAN UNION IN 2016

FIGURE 16 OCCURRENCE OF MIGRAINE AS PER THE AUSTRALIAN AND NEW ZEALAND ASSOCIATION OF NEUROLOGISTS ANNUAL SCIENTIFIC MEETING 2017

FIGURE 17 PROJECTED NUMBER OF PEOPLE WITH CHRONIC CONDITIONS (IN MILLIONS)

FIGURE 18 PERCENTAGE OF INTERNET USERS IN 2016 AND 2019

FIGURE 19 HEALTHCARE EXPENDITURE IN 2016 AND 2019

FIGURE 20 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY MECHANISM, 2019

FIGURE 21 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY MECHANISM, 2019-2027 (USD MILLION)

FIGURE 22 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY MECHANISM, CAGR (2020-2027)

FIGURE 23 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY MECHANISM, LIFELINE CURVE

FIGURE 24 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY CATEGORY, 2019

FIGURE 25 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY CATEGORY, 2019-2027 (USD MILLION)

FIGURE 26 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY CATEGORY, CAGR (2020-2027)

FIGURE 27 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY CATEGORY, LIFELINE CURVE

FIGURE 28 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY TREATMENT, 2019

FIGURE 29 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY TREATMENT, 2019-2027 (USD MILLION)

FIGURE 30 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY TREATMENT, CAGR (2020-2027)

FIGURE 31 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY TREATMENT, LIFELINE CURVE

FIGURE 32 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY SOFTWARE, 2019

FIGURE 33 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY SOFTWARE, 2019-2027 (USD MILLION)

FIGURE 34 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY SOFTWARE, CAGR (2020-2027)

FIGURE 35 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY SOFTWARE, LIFELINE CURVE

FIGURE 36 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY SERVICES, 2019

FIGURE 37 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY SERVICES, 2019-2027 (USD MILLION)

FIGURE 38 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY SERVICES, CAGR (2020-2027)

FIGURE 39 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY SERVICES, LIFELINE CURVE

FIGURE 40 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY APP ACCESSIBILITY, 2019

FIGURE 41 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY APP ACCESSIBILITY, 2019-2027 (USD MILLION)

FIGURE 42 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY APP ACCESSIBILITY, CAGR (2020-2027)

FIGURE 43 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY APP ACCESSIBILITY, LIFELINE CURVE

FIGURE 44 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY APP TYPE, 2019

FIGURE 45 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY APP TYPE, 2019-2027 (USD MILLION)

FIGURE 46 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY APP TYPE, CAGR (2020-2027)

FIGURE 47 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY APP TYPE, LIFELINE CURVE

FIGURE 48 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY APPLICATION, 2019

FIGURE 49 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY APPLICATION, 2019-2027 (USD MILLION)

FIGURE 50 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY APPLICATION, CAGR (2020-2027)

FIGURE 51 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 52 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY PATIENTS, 2019

FIGURE 53 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY PATIENTS, 2019-2027 (USD MILLION)

FIGURE 54 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY PATIENTS, CAGR (2020-2027)

FIGURE 55 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY PATIENTS, LIFELINE CURVE

FIGURE 56 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: SNAPSHOT (2019)

FIGURE 57 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY COUNTRY (2019)

FIGURE 58 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY COUNTRY (2020 & 2027)

FIGURE 59 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY COUNTRY (2019 & 2027)

FIGURE 60 ASIA- PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: BY MECHANISM (2020-2027)

FIGURE 61 ASIA-PACIFIC PRESCRIPTION DIGITAL THERAPEUTICS (PDTX) MARKET: COMPANY SHARE 2019 (%)

查看详细信息 Right Arrow

研究方法

数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。该阶段包括通过各种来源和策略获取市场信息或相关数据。它包括提前检查和规划从过去获得的所有数据。它同样包括检查不同信息源中出现的信息不一致。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。要了解更多信息，请请求分析师致电或下拉您的询问。

DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析和主要（行业专家）验证。数据模型包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、专利分析、定价分析、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息，请向我们的行业专家咨询。

可定制

Data Bridge Market Research 是高级形成性研究领域的领导者。我们为向现有和新客户提供符合其目标的数据和分析而感到自豪。报告可定制，包括目标品牌的价格趋势分析、了解其他国家的市场（索取国家列表）、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表（事实手册）中的数据，或者可以帮助您根据报告中的数据集创建演示文稿。

Frequently Asked Questions

The market value for Asia-Pacific Prescription Digital Therapeutics (PDTx) Market is expected USD 545.70 million by 2029.
The Prescription Digital Therapeutics (PDTx) Market is to grow at a CAGR of 24.2% during the forecast period of 2022 to 2029
On the basis of application, the Asia-Pacific Prescription Digital Therapeutics (PDTx) Marketis segmented into Substance Use Disorder (SUD), Opioid Use Disorder (OUD), Attention Deficit/Hyperactivity Disorder (ADHD), Alzheimer’s Disease, Major Depressive Disorder (MDD), Insomnia, Epilepsy, Movement Disorder, Multiple Sclerosis, Migraine, Autism Spectrum Disorder, Oncology, Inflammation, Respiratory, Cardiovascular, Pain Management, Metabolic Conditions, Others.
The major players operating in the Asia-Pacific Prescription Digital Therapeutics (PDTx) Market are ResMed (US), SAMSUNGHEALTHCARE (South Korea), Biofourmis (US), Novartis AG (Switzerland), Medtronic (Ireland), Pear Therapeutics, Inc. (US), Voluntis (France).

浏览相关页面

Banner
Testimonial
Image
Product manager, Fujifilms

Thankful to the team for the amazing coordination, and helping me at the last moment with my presentation. It was indeed a comprehensive report that gave us revenue impacting solution enabling us to plan the right move.

Image
Investor relations, GE Healthcare

Thank you for the report, and addressing our needs in such short time. DBMR has outdone themselves in this project with such short timeframe.

Image
Market Analyst, Medincell

We found the results of this study compelling and will help our organization validate a market we are considering to enter. Thank you for a job well done.

Image
Andrew - Senior Global Marketing Manager, Medtronic (US)

I want to thank you for your help with this report – It’s been very helpful in our business planning and it well organized.

Image
Amarildo - Manager, Global Strategic Alignment MasterCard

We believe the work done by Data Bridge Team for our requirements in the North America Loyalty Management Market was fantastic and would love to continue working with your team moving forward.

Image
Tor Hammer Green Nexus LLc

Thank you for your quick response to this unfortunate circumstance. Please extend my thanks to your reach team. I will be contacting you in the future with further projects

Image
Tommaso Finocchiaro Market Intelligence Specialist Nippon Gasses

I acknowledge the difficulty given by the very short warning for this report, and I think that its quality and your delivering time have been very satisfying. Obviously, as a provider Data Bridge Market Research will be considered as a plus for future needs of Nippon Gases.

Image
Yuki Kopyl (Asian Business Development Department) UENO FOOD TECHNO INDUSTRY, LTD. (JAPAN)

Xylose report was very useful for our team. Thank you very much & hope to work with you again in the future

Image
David Manning - Thermo Fisher Scientific Director, Global Strategic Accounts,
Dear Ricky, I want to thank you for the excellent market analysis (LIMS INSTALLED BASE DATA) that you and your team delivered, especially end of year on short notice. Sachin and Shraddha captured the requirements, determined their path forward and executed quickly.
You, Sachin and Shraddha have been a pleasure to work with – very responsive, professional and thorough. Your work is much appreciated.
Image
Manager - Market Analytics, Uriah D. Avila - Zeus Polymer Solutions
Thank you for all the assistance and the level of detail in the market report. We are very pleased with the results and the customization. We would like to continue to do business.
Image
Business Development Manager, (Pharmaceuticals Partner for Nasal Sprays) | Renaissance Lakewood LLC
DBMR was attentive and engaged while discussing the Global Nasal Spray Market. They understood what we were looking for and was able to provide some examples from the report as requested. DBMR Service team has been responsive as needed. Depending on what my colleagues were looking for, I will recommend your services and would be happy to stay connected in case we can utilize your research in the future.
Image
Business Intelligence and Analytics, Ipsen Biopharm Limited

We are impressed by the CENTRAL PRECOCIOUS PUBERTY (CPP) TREATMENT report - so a BIG thanks to you colleagues.

Image
Competition Analyst, Basler Web

I just wanted to share a quick note and let you know that you guys did a really good job. I’m glad I decided to work with you. I shall continue being associated with your company as long as we have market intelligence needs.

Image
Marketing Director, Buhler Group

It was indeed a good experience, would definitely recommend and come back for future prospects.

Image
COO, A global leader providing Drug Delivery Services

DBMR did an outstanding job on the Global Drug Delivery project, We were extremely impressed by the simple but comprehensive presentation of the study and the quality of work done. This report really helped us to access untapped opportunities across the globe.

Image
Marketing Director, Philips Healthcare

The study was customized to our targets and needs with well-defined milestones. We were impressed by the in-depth customization and inclusion of not only major but also minor players across the globe. The DBMR Market position grid helped us to analyze the market in different dimension which was very helpful for the team to get into the minute details.

Image
Product manager, Fujifilms

Thankful to the team for the amazing coordination, and helping me at the last moment with my presentation. It was indeed a comprehensive report that gave us revenue impacting solution enabling us to plan the right move.

Image
Investor relations, GE Healthcare

Thank you for the report, and addressing our needs in such short time. DBMR has outdone themselves in this project with such short timeframe.

Image
Market Analyst, Medincell

We found the results of this study compelling and will help our organization validate a market we are considering to enter. Thank you for a job well done.

Image
Andrew - Senior Global Marketing Manager, Medtronic (US)

I want to thank you for your help with this report – It’s been very helpful in our business planning and it well organized.

Image
Amarildo - Manager, Global Strategic Alignment MasterCard

We believe the work done by Data Bridge Team for our requirements in the North America Loyalty Management Market was fantastic and would love to continue working with your team moving forward.

Image
Tor Hammer Green Nexus LLc

Thank you for your quick response to this unfortunate circumstance. Please extend my thanks to your reach team. I will be contacting you in the future with further projects

Image
Tommaso Finocchiaro Market Intelligence Specialist Nippon Gasses

I acknowledge the difficulty given by the very short warning for this report, and I think that its quality and your delivering time have been very satisfying. Obviously, as a provider Data Bridge Market Research will be considered as a plus for future needs of Nippon Gases.

Image
Yuki Kopyl (Asian Business Development Department) UENO FOOD TECHNO INDUSTRY, LTD. (JAPAN)

Xylose report was very useful for our team. Thank you very much & hope to work with you again in the future

Image
David Manning - Thermo Fisher Scientific Director, Global Strategic Accounts,
Dear Ricky, I want to thank you for the excellent market analysis (LIMS INSTALLED BASE DATA) that you and your team delivered, especially end of year on short notice. Sachin and Shraddha captured the requirements, determined their path forward and executed quickly.
You, Sachin and Shraddha have been a pleasure to work with – very responsive, professional and thorough. Your work is much appreciated.
Image
Manager - Market Analytics, Uriah D. Avila - Zeus Polymer Solutions
Thank you for all the assistance and the level of detail in the market report. We are very pleased with the results and the customization. We would like to continue to do business.
Image
Business Development Manager, (Pharmaceuticals Partner for Nasal Sprays) | Renaissance Lakewood LLC
DBMR was attentive and engaged while discussing the Global Nasal Spray Market. They understood what we were looking for and was able to provide some examples from the report as requested. DBMR Service team has been responsive as needed. Depending on what my colleagues were looking for, I will recommend your services and would be happy to stay connected in case we can utilize your research in the future.
Image
Business Intelligence and Analytics, Ipsen Biopharm Limited

We are impressed by the CENTRAL PRECOCIOUS PUBERTY (CPP) TREATMENT report - so a BIG thanks to you colleagues.

Image
Competition Analyst, Basler Web

I just wanted to share a quick note and let you know that you guys did a really good job. I’m glad I decided to work with you. I shall continue being associated with your company as long as we have market intelligence needs.

Image
Marketing Director, Buhler Group

It was indeed a good experience, would definitely recommend and come back for future prospects.

Image
COO, A global leader providing Drug Delivery Services

DBMR did an outstanding job on the Global Drug Delivery project, We were extremely impressed by the simple but comprehensive presentation of the study and the quality of work done. This report really helped us to access untapped opportunities across the globe.

Image
Marketing Director, Philips Healthcare

The study was customized to our targets and needs with well-defined milestones. We were impressed by the in-depth customization and inclusion of not only major but also minor players across the globe. The DBMR Market position grid helped us to analyze the market in different dimension which was very helpful for the team to get into the minute details.